3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Urogenital Neoplasms
1
Ovarian Neoplasms
1
Ovarian Diseases
1
Ovarian Cysts
1
Neoplasms
1
Gonadal Disorders
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Endocrine System Diseases
1
Endocrine Gland Neoplasms
1
Disease
1
Cysts
1
Adnexal Diseases
1
Interventions
Educational Status
3
pembrolizumab
2
anlotinib
2
Therapeutic Touch
2
Surveys and Questionnaires
2
Standard of Care
2
Radiotherapy
2
Palliative Care
2
Methods
2
Interviews as Topic
2
Early Intervention, Educational
2
Carboplatin
2
temsirolimus
1
olaparib
1
niraparib
1
fosaprepitant
1
argatroban
1
Topotecan
1
Thrombopoietin
1
Surgical Procedures, Operative
1
Practice Guidelines as Topic
1
Palonosetron
1
Paclitaxel
1
Nivolumab
1
Ipilimumab
1
Heparin, Low-Molecular-Weight
1
Filgrastim
1
Dimenhydrinate
1
Diffusion
1
Diet
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Genital Neoplasms, Female
×
Diffusion
×
Clear all
NCT02836275
2020-04-14
IOTA-MRI
KU Leuven
Phase NA
Unknown
250 enrolled